MedPath

Clinical study on the efficacy and safety of ganghuokanggan granule in the treatment of dengue fever

Phase 1
Not yet recruiting
Conditions
dengue fever
Registration Number
ITMCTR2100004502
Lead Sponsor
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Those who meet the diagnostic criteria of dengue fever in acute fever stage of Western medicine.

(2) It is in accordance with the syndrome differentiation and diagnosis standard of heat dampness depression and Wei Qi disease.

(3) The age ranged from 18 to 65 years (including 18 and 65 years).

(4) The onset time was less than 5 days, without TCM treatment.

(5) According to GCP, informed consent was obtained and volunteers were enrolled.

Exclusion Criteria

The clinical diagnostic criteria of dengue fever were not met

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.